Regenxbio (RGNX) Retained Earnings (2014 - 2025)

Regenxbio's Retained Earnings history runs 12 years deep, the most recent figure standing at -$1.1 billion for Q4 2025.

• In Q4 2025, Retained Earnings fell 151860.46% year-over-year to -$1.1 billion; the TTM figure through Dec 2025 stood at -$1.1 billion (down 151860.46% YoY), while the FY2025 annual figure was -$1.1 billion, down 151860.46% from the prior year.
• Retained Earnings was -$1.1 billion for Q4 2025 at Regenxbio, down from -$1.1 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$741000.0 in Q4 2024 to a low of -$1.1 billion in Q4 2025.
• Historically, Retained Earnings has averaged -$365.5 million across 5 years, with a median of -$250.2 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Retained Earnings slumped 173200.76% in 2021, then surged 99.91% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$161.2 million in 2021, then soared by 90.45% to -$15.4 million in 2022, then surged by 71.24% to -$4.4 million in 2023, then soared by 83.27% to -$741000.0 in 2024, then tumbled by 151860.46% to -$1.1 billion in 2025.
• The last three Retained Earnings figures came in at -$1.1 billion (Q4 2025), -$1.1 billion (Q3 2025), and -$750000.0 (Q2 2025), per Business Quant data.